This content is machine translated Psoriasis treatment with biologics What are the latest trends? Novel oral therapies are currently being researched – promising data from clinical trials is now available. In the field of approved, subcutaneously administered IL-23 and IL-17 antagonists, current real-world data...…
View Post 9 min This content is machine translated Psoriasis in locations that are difficult to treat New study data on IL-23 inhibition When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved...…
View Post 4 min This content is machine translated Inflammatory memory in psoriasis Timing of biologics therapy is crucial The pathogenesis of psoriasis is complex, but is becoming increasingly better understood. With the modern substance classes of interleukin (IL)-17 and IL-23 inhibitors, highly effective biologics are now available for…
View Post 5 min This content is machine translated SDNTT register data Psychological comorbidities in psoriasis Inflammatory systemic diseases such as psoriasis are associated with a high risk of comorbidity. In addition to cardiometabolic diseases, mental disorders are particularly common in this patient population. As part…
View Post 9 min This content is machine translated System therapy for psoriasis Expanded possibilities thanks to practical innovations Compared to the past, there are now more and more effective systemic therapies available. This has been helped by a surge in innovation that has produced a wide range of…
View Post 7 min This content is machine translated Systemic disease psoriasis Keep an eye on comorbidities Comorbidities may already be present at the initial manifestation of plaque psoriasis, but sometimes these only develop later in the course of the disease. Taking this into account appropriately can…
View Post 4 min This content is machine translated "Psoriasis and Beyond" Insight into the patient’s perspective In order to better understand the experiences and views of patients affected by psoriasis and psoriatic arthritis, a survey of almost 5,000 patients was conducted on four continents worldwide.One focus…
View Post 4 min This content is machine translated TYK2 inhibition in psoriasis What’s new? The JAK-STAT pathway mediates a variety of proinflammatory responses through Janus kinases (JAK)1-3 andtyrosine kinase-2 (TYK2).Deucravacitinib selectively inhibits TYK2 and was shown to be effective and safe in patients with…
View Post 4 min This content is machine translated IL-23-i for psoriasis Real-world studies with a focus on PROs Individual therapy goals are playing an increasingly important role in the modern, guideline-oriented treatment of psoriasis. In this context, real-world studies with biologics often not only record the reduction in…
View Post 3 min This content is machine translated Psoriasis in special localizations Associated with an increased level of suffering Even in patients with only mild or moderate psoriasis, the scalp, face, soles of the feet, palms of the hands, nails and genitals are often affected. This can have a…
View Post 2 min This content is machine translated Severe asthma and psoriasis Biologics combination leads to success Biologics are now established treatment options, particularly for severe courses of the disease. However, there is little data on the the efficacy and safety of simultaneous administration of several biologics…
